Although the burden of end-stage heart failure continues to increase, the number of
available organs for heart transplantation (HT) remains inadequate. The HT community has …

The growing disparity between the supply of donor hearts for transplantation and the
demand for such organs has led to liberalization of the criteria for donor heart acceptance …

Disparities in organ acceptance practices exacerbate donor heart nonuse and lead to
increased waiting times and mortality for heart transplant candidates. We studied disparities …

The first human-to-human heart transplant was performed 50 years ago in 1967. Heart
transplantation has now entered an era of tremendous growth and innovation. The future of …

Approximately 65 million adults globally have heart failure, and the prevalence is expected
to increase substantially with ageing populations. Despite advances in pharmacological and …

Background: Strategies to improve donor heart utilization are required in the setting of
limited donor availability. One innovative strategy is to consider the use of hepatitis C viremic …

Heart transplantation has become the accepted treatment for advanced heart failure, with
over 4000–5000 performed in the world annually. Although the number of yearly transplants …

Advanced heart failure affects tens of thousands of people in the United States alone with
high morbidity and mortality. Cardiac transplantation offers the best treatment strategy, but …

Heart transplantation continues to be limited by a paucity of donor organs despite
innovations in organ procurement and organ preservation, greater willingness to accept …

Purpose of review With increasing survival of patients with stage D heart failure, the demand
for heart transplantation has increased. The supply of donor hearts remains relatively …